Parexel pens CluePoints collab for risk-based monitoring work
by Ben Adams Jun 20, 2019 7:55am
Parexel is looking to bolster its clinical trial work and compliance by signing a new deal with CluePoints.
FDA clears J&J and Grifols' blood-stopping protein spray
by Conor Hale Jun 19, 2019 12:44pm
J&J’s Ethicon unit received an FDA clearance for its Vistaseal applicators that spray a biologic sealant from Grifols to help stem surgical bleeding.
Gilead taps Nurix's protein degradation tech in $45M cancer pact
by Amirah Al Idrus Jun 19, 2019 10:58am
Gilead Sciences is paying Nurix $45 million upfront in a deal that could reach $2.3 billion in value if all milestones are met and royalties realized.
Bio-Techne nets FDA breakthrough ticket for prostate cancer test
by Conor Hale Jun 19, 2019 10:33am
Bio-Techne’s urine test has received a breakthrough device designation from the FDA for ruling out unnecessary tissue biopsies.
Kymera targets protein degradation to treat lymphoma
by Arlene Weintraub Jun 19, 2019 10:31am
In mice, Kymera's lead drug promoted tumor regression, both on its own and in combination with BTK inhibitor Imbruvica.
Distrust is frustrating U.K. NHS-industry cooperation: report
by Nick Paul Taylor Jun 19, 2019 9:30am
The report features testimony that some NHS bodies are “actively instructed not to deal with industry by their local leadership.”
Schrödinger hires ex-Eisai, Merck staff for push into clinic
by Nick Paul Taylor Jun 19, 2019 8:52am
News of the hires comes weeks after Schrödinger pulled in more cash to fund its evolution into a biotech with an internal pipeline.
Canaan-backed Comet uncloaks with $28.5M and De Graaf as CEO
by Amirah Al Idrus Jun 19, 2019 7:00am
Comet Therapeutics unveiled itself with $28.5 million in series A financing and biopharma veteran David De Graaf at the helm.
Qiagen launches one-stop antimicrobial resistance database
by Conor Hale Jun 18, 2019 11:17am
Qiagen launched a one-stop shop compiling publicly available genomic data, scientific literature and phenotypic information on potential superbugs.
J&J leads $7M round for digital health co. Cara Care
by Amirah Al Idrus Jun 18, 2019 10:53am
Cara Care, a digital health startup focused on digestive diseases, raised $7 million to bring its mobile app to more patients in the U.S.